TOI Q4 earnings call transcript

What happened: Topicus.com Inc. (TOI.V) reported a 24% drop in Q1 earnings to EUR34.21 million, or EUR0.41 per share, compared to EUR44.81 million, or EUR0.54 per share, in Q1 2025. Meanwhile, Oncology Institute (TOI) reported a 15% increase in revenue to EUR120 million in Q4 2025. IRIDEX (IRIX) and Cibus (CBUS) held earnings calls but did not report significant changes.

Market impact: The earnings miss by Topicus.com, a tech and software company, could weigh on the broader technology sector, particularly software-as-a-service (SaaS) stocks. Oncology Institute's strong performance may boost investor confidence in the healthcare sector, specifically biotechnology and cancer treatment companies.

What to watch next: Topicus.com's Q2 2026 earnings call on May 26, 2026, to see if the company can rebound from its Q1 earnings miss. Oncology Institute's Q1 2027 earnings call, expected in early 2027, will provide an update on its growth trajectory. Additionally, investors should monitor the overall technology and healthcare sector performance, as these sectors' performance may influence the trajectory of TOI.V and TOI stock prices.